CONTACT US   |  (864) 397-5101

RESI South IPC Finalists

A poster with a city in the background.

The RESI SouthInnovator’s Pitch Challenge (IPC) finalists are in! The IPC will include 11 sessions for finalist companies to pitch to a judging panel featuring investors and industry experts. In addition, each company will be presenting a posterboard in the RESI exhibit hall throughout the conference. All RESI attendees will be given 5 pieces of “RESI Cash,” which can be used to “invest” or vote for their favorite companies, and the 3 companies with the highest number of votes will be announced at the end of RESI with a prize and newsletter feature.

South Carolina companies selected for the Pitch Contest are Leukogene Therapeutics, Lucie Medical, NueroQuest, and Precision Genetics.

Participating in the IPC is an unparalleled opportunity for actively fundraising startups to boost their exposure and engage a wider network of global investors and strategic partners.

Click here for the list of IPC Finalists.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.